Total Funding
6
Total FundingSeed raised
Growth Score
pts
Heat Score
4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
2993364
Lymphact is a biopharmaceutical start-up focused on developing innovative personalized medical treatments.
About the Company
Lymphact is a biopharmaceutical start-up focused on developing innovative personalized medical treatments. Their products and technologies are designed to harness the power of the immune system, the target-specific cellular mechanism which evolved in vertebrates during the last 450 million years, towards a permanent elimination of pathogens. After
5 years of pioneering research and development in this field, they created a new technology platform which can generate autologous and allogeneic cellular immune therapies for clinical applications: DOT-Cells®.
